These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 558637)

  • 21. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.
    Hamberg M; Svensson J; Samuelsson B
    Proc Natl Acad Sci U S A; 1975 Aug; 72(8):2994-8. PubMed ID: 1059088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of platelet aggregation by 1-alkylimidazole derivatives, thromboxane A synthetase inhibitors.
    Kayama N; Sakaguchi K; Kaneko S; Kubota T; Fukuzawa T; Kawamura S; Yoshimoto T; Yamamoto S
    Prostaglandins; 1981 Apr; 21(4):543-54. PubMed ID: 7196056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of thromboxane A2 biosynthesis in human platelets by burimamide.
    Allan G; Eakins KE; Kulkarni PS; Levi R
    Br J Pharmacol; 1980; 71(1):157-64. PubMed ID: 6781572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphonuclear leukocytes produce thromboxane A2-like activity during phagocytosis.
    Higgs GA; Bunting S; Moncada S; Vane JR
    Prostaglandins; 1976 Nov; 12(5):749-57. PubMed ID: 981700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostaglandin endoperoxides and thromboxanes: formation and effects.
    Moncada S
    Naunyn Schmiedebergs Arch Pharmacol; 1977; 297 Suppl 1():S81-4. PubMed ID: 859657
    [No Abstract]   [Full Text] [Related]  

  • 26. Selective inhibition of prostaglandin endoperoxide thromboxane isomerase by 1-carboxyalkylimidazoles.
    Yoshimoto T; Yamamoto S; Hayaishi O
    Prostaglandins; 1978 Oct; 16(4):529-40. PubMed ID: 725083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 9,11-Iminoepoxyprosta-5,13-dienoic acid is a selective thromboxane A2 synthetase inhibitor.
    Fitzpatrick F; Gorman R; Bundy G; Honohan T; McGuire J; Sun F
    Biochim Biophys Acta; 1979 May; 573(2):238-44. PubMed ID: 375987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of thromboxane A2 by non-aggregating dog platelets challenged with arachidonic acid or with prostaglandin H2.
    Chignard M; Vargaftig BB
    Prostaglandins; 1977 Aug; 14(2):222-40. PubMed ID: 197571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical properties of the prostaglandin/thromboxane synthetase of human blood platelets and comparison with the synthetase of bovine seminal vesicles.
    White HL; Glassman AT
    Prostaglandins; 1976 Nov; 12(5):811-28. PubMed ID: 10602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of endoperoxides and thromboxanes in anaphylactic reactions.
    Hamberg M; Svensson J; Hedqvist P; Strandberg K; Samuelsson B
    Adv Prostaglandin Thromboxane Res; 1976; 1():495-501. PubMed ID: 998440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the inhibitory potency of imidazole and its derivatives on thromboxane synthetase.
    Tai HH; Yuan B
    Biochem Biophys Res Commun; 1978 Jan; 80(1):236-42. PubMed ID: 623654
    [No Abstract]   [Full Text] [Related]  

  • 32. On the formation and effects of thromboxane A2 in human platelets.
    Svensson J; Hamberg M; Samuelsson B
    Acta Physiol Scand; 1976 Nov; 98(3):285-94. PubMed ID: 998278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors.
    Rajtar G; Cerletti C; Castagnoli MN; Bertelé V; de Gaetano G
    Biochem Pharmacol; 1985 Feb; 34(3):307-10. PubMed ID: 3918536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of PGE1-stimulated cAMP accumulation in human platelets by thromboxane a2.
    Miller OV; Johnson RA; Gorman RR
    Prostaglandins; 1977 Apr; 13(4):599-609. PubMed ID: 193153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistence of thromboxane A2-like material and platelet release-inducing activity in plasma.
    Smith JB; Ingerman C; Silver MJ
    J Clin Invest; 1976 Nov; 58(5):1119-22. PubMed ID: 993335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation.
    Moncada S; Gryglewski RJ; Bunting S; Vane JR
    Prostaglandins; 1976 Nov; 12(5):715-37. PubMed ID: 824686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostaglandin and thromboxane synthesis by microsomes of rabbit ocular tissues.
    Kass MA; Holmberg NJ
    Invest Ophthalmol Vis Sci; 1979 Feb; 18(2):166-71. PubMed ID: 761971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostaglandin biosynthesis in platelets: demonstration and role of prostaglandin H2 leads to E2 isomerase.
    Raz A; Aharony D
    Res Commun Chem Pathol Pharmacol; 1978 Sep; 21(3):507-15. PubMed ID: 705027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel transformations of prostaglandin endoperoxides: formation of thromboxanes.
    Hamberg M; Svensson J; Samuelsson B
    Adv Prostaglandin Thromboxane Res; 1976; 1():19-27. PubMed ID: 1033661
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.